Product
[18F]GTP1
2 clinical trials
2 indications
Indication
Alzheimer diseaseIndication
Alzheimer's DiseaseClinical trial
Phase 1 Evaluation Comparing Tau PET Radiotracers, [18F]GTP1 and [18F]PI-2620 or [18F]MK-6240 in Subjects With Normal Cognition or Prodromal to Moderate Alzheimer's DiseaseStatus: Completed, Estimated PCD: 2023-06-27
Clinical trial
A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, and Safety Study of MTAU9937A in Patients With Moderate Alzheimer's DiseaseStatus: Completed, Estimated PCD: 2021-07-20